Application no. and date | 15848512.8 (espacenet) (Federated) (European Patent Register), 20151009 | Patent/reg. no. and date | DK/EP 3204015, 20211208 | Publication date | 20170816 | Priority no. and date | US 201462062751 P, 20141010, US 201562147976 P, 20150415, US 201562214602 P, 20150904 | EP pub. no. and date |
EP 3204015 20170816 | Effective date | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street, Henri. A. Termeer Square
Cambridge, MA 02142, US | Applicant ref. no. | 1612943 | Inventor | QUERBES, William, 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US, FITZGERALD, Kevin, 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US, BETTENCOURT, Brian, 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US, LIEBOW, Abigail, 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US, ERBE, David V., 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/713 (2006.01) , C12N 15/113 (2010.01) , C07H 21/02 (2006.01) | Title | FORBINDELSER OG FREMGANGSMÅDER TIL INHIBITION AF HAO1-GENEKSPRESSION (HYDROXYSYRE OXIDASE 1 (GLYCOLAT OXIDASE)) | Int. application no. | US2015054881 | Int. publication no. | WO2016057893 | Related patent (certificate) | CA 2022 00011 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|